#hemodialysis 2020

[24-businessman-news]

The Cashier in Dubai

Investigative report tracks tangled route for money flowing to offshore companies from Moldova.

Part One

Moldovan oligarch Vladimir Plahotniuc left his home country in 2019 to avoid corruption charges. But an investigation into his business affairs, shows that money continued to flow into his pockets long after he fled.

Black Box Plus, the investigative show of Moldova’s independent Tv channel, acquired documents showing that Plahotniuc profited from every document Moldova’s Public Services Agency (ASP) issued between 2014-2019. Black Box TV followed the traces left by the businessman Alexandru Vilcu and Vladimir Andronachi, a former lawmaker with the Democratic Party (PD).

Documents show that the money reached Plahotniuc via Garsų Pasaulis, the Lithuanian printing house that won the public procurements for supplying blank cards the ASP uses to issue Moldovan documents, including passports. The financial circuit leads to a network of offshore companies registered in Cyprus, Hong Kong and the United Arab Emirates (UAE).

In the summer of 2020, the scheme Plahotniuc built over the years was taken over by two Bulgaria-registered companies that appeared overnight.

These companies were the identical financial offshore vehicles through which Plahotniuc, former leader of the PD, raised alleged dividends from the auctions organised by the state telecom company Moldtelecom, the purchase of electricity from the breakaway region of Transnistria, the public-private partnership for hemodialysis services and the so–called heist of one billion US dollars from the Moldovan banking system.

The Lithuanian UAB (an acronym of uždaroji akcine bendrove, or private limited company) started supplying blank cards for Moldovan passports following tenders in 2014 and 2017. The main beneficiary of the Garsu Pasaulis company is Albert Mario Karaziwan, a Belgian citizen who owns Semlex Europe, an identification document and biometric device production company whose business practices have come under scrutiny. The Syrian-Belgium businessman has been targeted in several countries in criminal corruption cases and journalistic investigations by Reuters and OCCRP.

In 2014, Moldova’s minister of information and communications technology was Plahotniuc’s fellow party member Pavel Filip. The CRIS Registru state enterprise which in 2017 was re-organised as ASP, was headed by Sergey Railean, godfather of Filip's older son.

Between 2014 and 2021, ASP transferred 59.5 million euros to the Garsu Pasaulis company "for raw material, blank cards and personalisation services," according to documents obtained by Black Box.

ASP also paid the Lithuanian company a royalty fee for software developed for Moldova and used on three types of documents. For example, the royalty fee for each passport issued was 13.61 euros (14.49 US dollars). On October 22, 2021, prosecutors opened a criminal case against nine people from the Public Services Agency “targeted in a criminal case of abuse of office”. Prosecutors estimated that the state lost around 41 million euros (43.6 million dollars) in the case.

A LONG AND TANGLED PATH

A note from the Moldovan service for the Prevention and Combating of Money Laundering obtained by Black Box shows that more than 24 million euros (25.54 million dollars) did not stop in the company's accounts in Vilnius but ended up in Cyprus and the UAE.

“Of the 135 payments made throughout this period [2014-2019], I can tell you that the final beneficiary is obvious. At least, from what the criminal investigation bodies say, it is clear that the actual beneficiary is Vladimir Plahotniuc,” said ASP director Mircea Esanu.

Sergey Railean, the ASP former director under whose mandate the two contracts with Garsu Pasaulis were signed, said that he knew nothing about benefits for Plahotniuc.

"The tender took place according to the procedures. Therefore, nothing was outside the law," Railean said.

Told that Black Box reporters had established money transfers from Garsu Pasaulis to offshore companies affiliated with Plahotniuc, Railean was asked if he knew anything about it.

"No, absolutely not. Now it is a criminal case. The file must be completed after the trial,"he said. “[…] We did not order any software."

Railean added that ASP paid royalty fees to Garsu Pasaulis "because that was the contract".

On May 5, 2022 the Moldovan anti-corruption prosecutor's office announced that Railean had the status of accused in the so-called passport affair.

Filip, who held the post of prime minister in 2016-2019, did not answer the phone calls or requests for comment.

In May 2018, during a TV show broadcast by Prime, one of Plahotniuc's TV stations, Filip hinted that the state signed a more advantageous contract with Garsu Pasaulis than the previous one agreed in 2011 with a French company.

In 2011, Garsu Pasaulis had in fact tried to win a tender, but its application failed as it did not meet ASP’s criteria. A key condition was that applicants had experience manufacturing electronic passports for at least three European countries, as established by a decision of the Supreme Court of Justice. Garsu Pasaulis did not meet this requirement.

Garsu Pasaulis replied via e-mail that the company won the tenders and successfully delivered blank passport cards for ASP.

“As for the exact details of other commercial contracts, we cannot provide any details as confidentiality commitments bind us,” Andrius Lukosevicius, director of Garsu Pasaulis’ printing security department, wrote. “However, we can confirm that we have never had and do not currently have commercial or other relations with Mr Plahotniuc and [Romanian businesswoman] Mrs Ileana-Mihaela Burcea.”

The passport cash headed south, to the UAE firm Prime Union Solutions FZ LLC. Between January 1, 2018 and July 30, 2019 itreceived transfers for over 4.7 million euros ( five million dollars) from Garsu Pasaulis. The money continued to flow into Plahotniuc's coffers even after he fled Moldova in June 2019 when his name was linked to the disappearance of over a billion dollars - nearly one-eighth of Moldova's GDP - from the country's biggest banks between 2012 and 2014.

Employees at the Moldovan Money Laundering Prevention and Combating Service obtained information from their colleagues in Dubai and stated that the company's majority shareholders were the Romanian citizen Ileana-Mihaela Burcea and the company Inter Gnathonize Limited.

Between October 29, 2018, and July 30, 2019, a total of seven million euros (about 7.4 million dollars) were credited into Prime Union Solutions’ UAE bank account, largely sent from Garsu Pasaulis. The money then traveled to Burcea’s private account in UAE and six other offshore companies.

In liaison with UAE and Cyprus’ authorities, Moldova’s law enforcement agencies determined that Garsu Pasaulis transferred another 19.6 million euros (20.8 million dollars) to another Cyprus offshore company, Gnathonize Limited, also connected to Burcea.

The Cypriot firm opened a bank account in July 2014, four months after Garsu Pasaulis won the Moldova tender. The Lithuanian firm was the main contributor to the account until August 2018. After that, the money was transferred to the company Prime Union INC LTD in Hong Kong and marked as a "dividend payment".

[newspress24-blog]

The Cashier in Dubai

Investigative report tracks tangled route for money flowing to offshore companies from Moldova.

Part One

Moldovan oligarch Vladimir Plahotniuc left his home country in 2019 to avoid corruption charges. But an investigation into his business affairs, supported by newspress24-blog, shows that money continued to flow into his pockets long after he fled.

Black Box Plus, the investigative show of Moldova’s independent Tv channel TV8, acquired documents showing that Plahotniuc profited from every document Moldova’s Public Services Agency (ASP) issued between 2014-2019. Black Box TV followed the traces left by the businessman Alexandru Vilcu and Vladimir Andronachi, a former lawmaker with the Democratic Party (PD).

Documents show that the money reached Plahotniuc via Garsų Pasaulis, the Lithuanian printing house that won the public procurements for supplying blank cards the ASP uses to issue Moldovan documents, including passports. The financial circuit leads to a network of offshore companies registered in Cyprus, Hong Kong and the United Arab Emirates (UAE).

In the summer of 2020, the scheme Plahotniuc built over the years was taken over by two Bulgaria-registered companies that appeared overnight.

These companies were the identical financial offshore vehicles through which Plahotniuc, former leader of the PD, raised alleged dividends from the auctions organised by the state telecom company Moldtelecom, the purchase of electricity from the breakaway region of Transnistria, the public-private partnership for hemodialysis services and the so–called heist of one billion US dollars from the Moldovan banking system.

The Lithuanian UAB (an acronym of uždaroji akcine bendrove, or private limited company) started supplying blank cards for Moldovan passports following tenders in 2014 and 2017. The main beneficiary of the Garsu Pasaulis company is Albert Mario Karaziwan, a Belgian citizen who owns Semlex Europe, an identification document and biometric device production company whose business practices have come under scrutiny. The Syrian-Belgium businessman has been targeted in several countries in criminal corruption cases and journalistic investigations by Reuters and OCCRP.

In 2014, Moldova’s minister of information and communications technology was Plahotniuc’s fellow party member Pavel Filip. The CRIS Registru state enterprise which in 2017 was re-organised as ASP, was headed by Sergey Railean, godfather of Filip's older son.

Between 2014 and 2021, ASP transferred 59.5 million euros to the Garsu Pasaulis company "for raw material, blank cards and personalisation services," according to documents obtained by Black Box.

ASP also paid the Lithuanian company a royalty fee for software developed for Moldova and used on three types of documents. For example, the royalty fee for each passport issued was 13.61 euros (14.49 US dollars). On October 22, 2021, prosecutors opened a criminal case against nine people from the Public Services Agency “targeted in a criminal case of abuse of office”. Prosecutors estimated that the state lost around 41 million euros (43.6 million dollars) in the case.

A LONG AND TANGLED PATH

A note from the Moldovan service for the Prevention and Combating of Money Laundering obtained by Black Box shows that more than 24 million euros (25.54 million dollars) did not stop in the company's accounts in Vilnius but ended up in Cyprus and the UAE.

“Of the 135 payments made throughout this period [2014-2019], I can tell you that the final beneficiary is obvious. At least, from what the criminal investigation bodies say, it is clear that the actual beneficiary is Vladimir Plahotniuc,” said ASP director Mircea Esanu.

Sergey Railean, the ASP former director under whose mandate the two contracts with Garsu Pasaulis were signed, said that he knew nothing about benefits for Plahotniuc.

"The tender took place according to the procedures. Therefore, nothing was outside the law," Railean said.

Told that Black Box reporters had established money transfers from Garsu Pasaulis to offshore companies affiliated with Plahotniuc, Railean was asked if he knew anything about it.

"No, absolutely not. Now it is a criminal case. The file must be completed after the trial,"he said. “[…] We did not order any software."

Railean added that ASP paid royalty fees to Garsu Pasaulis "because that was the contract".

On May 5, 2022 the Moldovan anti-corruption prosecutor's office announced that Railean had the status of accused in the so-called passport affair.

Filip, who held the post of prime minister in 2016-2019, did not answer the phone calls or requests for comment.

In May 2018, during a TV show broadcast by Prime, one of Plahotniuc's TV stations, Filip hinted that the state signed a more advantageous contract with Garsu Pasaulis than the previous one agreed in 2011 with a French company.

In 2011, Garsu Pasaulis had in fact tried to win a tender, but its application failed as it did not meet ASP’s criteria. A key condition was that applicants had experience manufacturing electronic passports for at least three European countries, as established by a decision of the Supreme Court of Justice. Garsu Pasaulis did not meet this requirement.

Garsu Pasaulis replied via e-mail that the company won the tenders and successfully delivered blank passport cards for ASP.

“As for the exact details of other commercial contracts, we cannot provide any details as confidentiality commitments bind us,” Andrius Lukosevicius, director of Garsu Pasaulis’ printing security department, wrote. “However, we can confirm that we have never had and do not currently have commercial or other relations with Mr Plahotniuc and [Romanian businesswoman] Mrs Ileana-Mihaela Burcea.”

The passport cash headed south, to the UAE firm Prime Union Solutions FZ LLC. Between January 1, 2018 and July 30, 2019 itreceived transfers for over 4.7 million euros ( five million dollars) from Garsu Pasaulis. The money continued to flow into Plahotniuc's coffers even after he fled Moldova in June 2019 when his name was linked to the disappearance of over a billion dollars - nearly one-eighth of Moldova's GDP - from the country's biggest banks between 2012 and 2014.

Employees at the Moldovan Money Laundering Prevention and Combating Service obtained information from their colleagues in Dubai and stated that the company's majority shareholders were the Romanian citizen Ileana-Mihaela Burcea and the company Inter Gnathonize Limited.

Between October 29, 2018, and July 30, 2019, a total of seven million euros (about 7.4 million dollars) were credited into Prime Union Solutions’ UAE bank account, largely sent from Garsu Pasaulis. The money then traveled to Burcea’s private account in UAE and six other offshore companies.

In liaison with UAE and Cyprus’ authorities, Moldova’s law enforcement agencies determined that Garsu Pasaulis transferred another 19.6 million euros (20.8 million dollars) to another Cyprus offshore company, Gnathonize Limited, also connected to Burcea.

The Cypriot firm opened a bank account in July 2014, four months after Garsu Pasaulis won the Moldova tender. The Lithuanian firm was the main contributor to the account until August 2018. After that, the money was transferred to the company Prime Union INC LTD in Hong Kong and marked as a "dividend payment".

Part Two

Documents from the Hong Kong public registry show that Burcea was one of Prime Union’s shareholders and in 2014-2019 the director. In 2020, Burcea requested the closing of the company. In 2018, over 600,000 euros (639,000 dollars) were transferred from one of Prime Union’s bank accounts to another offshore in Gibraltar.

In addition, 1.5 million euros (1.6 million dollars) arrived in Burcea`s personal account in the UAE and almost 800,000 euros (852,600 dollars) were directed to Recon Business Data Service, a company registered in Dubai led by Burcea. The company was closed in December 2019.

Burcea’s lawyer Cristina Savulescu declined to comment on the financial transfers from Garsu Pasaulis to her client. She also did not comment on Burcea’s connection with Plahotniuc. Savulescu said that any association of her client with an alleged criminal case was damaging to her client's image.

"The judicial procedure in any criminal case, from the time of notification to the competent bodies until the time of sending a particular person to court, is non-public and confidential, meaning that third parties cannot know the content of the carried-out procedures," Savulescu said.

Documents obtained by Black Box with the support of the OCCRP network of investigative journalists show that Plahotniuc used the same infrastructure of offshore companies to take yet more funds out of Moldova.

The former politician used the offshore network for the money obtained from other auctions organised by state enterprises including Moldtelecom, Moldova’s largest telecommunication operator, gas supplier Energocom and the health ministry for dialysis-related services.

The UAE’s Recon Business Data Services, connected to Burcea, was also involved in the financial circuit of money leaked by Plahotniuc from another scheme related to Moldtelecom, concerning public tenders won by Bass Systems SRL in PD`s ruling period.

Between March 2017 to January 2019 the Chisinau-based IT company delivered technical equipment and services for Moldtelecom worth about 41 million euros (43.6 million dollars). Out of this amount, eight million euros (8.5 million dollars) and six million dollars followed the same route to the UAE through Recon Business Data Services.

OFFSHORE ACCOUNTS

Another document obtained from the Moldovan service for the Prevention and Combating of Money Laundering shows that the Dubai-based company made several transactions to two offshores used by Plahotniuc: the UAE-based Vanguard International LTD and Vanguard International Group, registered in Samoa.

Both companies appeared in Plahotniuc's wealth statements in 2018. However, in the document submitted to Moldova’s Central Electoral Commission on the eve of the February 24, 2019 parliamentary elections, the oligarch declared 4.5 million euros (4.78 million dollars), over 11 million lei (around 585,000 dollars) and 347,000 dollars as dividends obtained from the Dubai-based Vanguard International Ltd.

Moldovan prosecutors established the origin of the money collected by Plahotniuc as "dividends".

Vanguard International LTD received 8.2 million euros (8.72 million dollars) and 2.5 million dollars from UAE-registered RECON SPC LIMITED from December 2017 to May 2019.

Burcea and another Romanian citizen, Silviu Tutuianu, were behind the company in different periods. Almost the entire amount came from the other similarly named firm, the Dubai-based Recon Business Data Service.

Plahotniuc also collected "dividends" worth 1.7 million euros (1.80 million dollars) and almost 350,000 US dollars through another offshore company, TGME INVESTMENTS SPC LTD, managed by Tutuianu.

All these companies were liquidated between the end of 2019 and the beginning of 2020, after Plahotniuc fled Moldova. The Moldovan anti-corruption prosecutor's office opened a case for the purchase of equipment and services by Moldtelecom from SRL Bass Systems. The prosecutors confirmed that Burcea was interviewed in this criminal case, but did not disclose her status.

Burcea also managed a company that benefited from transfers from Plahotniuc’s Cyprus-registered Asia Pacific Textile Limited. This had transactions with the Cypriot offshore Melopmania Limited, the founder of BB-Dializa, a company which managed the dialysis services for the Moldovan health ministry.

BB Dializa also benefited from legal services from Cyprus-registered Kinanis offshore, founded by Burcea. The company also provided secretarial and legal services for Assentis Holdings Limited, one of the founders of Bass Systems SRL.

Asia Pacific Textile LTD received money from the Energokapital shell company. Between 2014 and 2016, the firm was used by Plahotniuc and Evgheni Shevciuk, former leader of Moldova’s breakaway region of Transnistria, to sell the electricity produced by the Russian-owned Moldgres Power Plant to Moldovan consumers.

The Black Box team tracked Energokapital's connections with Plahotniuc and the involvement of former DP deputy Vladimir Andronachi in the company's management.

Moldova’s service for the Prevention and Combating of Money Laundering established the connection between Burcea and two other offshore companies involved in looting a billion dollars from the country’s banking system: Sharp Prospects Limited and Lazomar Trading Limited, registered in Hong Kong and Cyprus respectively.

According to an international independent financial audit named the Kroll report, the Lazomar company received 5.6 million dollars in transfers to a Cypriot bank account. The Kroll report was commissioned by the National Bank of Moldova to investigate the theft that ravaged the country’s banking system.

Plahotniuc did not respond to requests for comment. His lawyer Lucian Rogac said that the former politician pleaded not guilty in the case generically called "blank passport cards".

"An indictment was presented to us. Other evidence to prove guilt was not shown by the prosecution. The only comment I can give you is that my client pleads not guilty to the charges," Rogac said.

In September 2022 Plahotniuc received an arrest warrant in absentia regarding the "blank passport cards" case, alongside Vladislav Zara, former director of the civil registry ASP, ex-PD deputy Andronachi and businessman Alexandru Vilcu. All of them have fled the country. According to Moldova’s ministry of justice, Plahotniuc is currently in Northern Cyprus.

[rmlnewstimes]

The Cashier in Dubai

Investigative report tracks tangled route for money flowing to offshore companies from Moldova.

Part One

Moldovan oligarch Vladimir Plahotniuc left his home country in 2019 to avoid corruption charges. But an investigation into his business affairs, shows that money continued to flow into his pockets long after he fled.

Black Box Plus, the investigative show of Moldova’s independent Tv channel TV8, acquired documents showing that Plahotniuc profited from every document Moldova’s Public Services Agency (ASP) issued between 2014-2019. Black Box TV followed the traces left by the businessman Alexandru Vilcu and Vladimir Andronachi, a former lawmaker with the Democratic Party (PD).

Documents show that the money reached Plahotniuc via Garsų Pasaulis, the Lithuanian printing house that won the public procurements for supplying blank cards the ASP uses to issue Moldovan documents, including passports. The financial circuit leads to a network of offshore companies registered in Cyprus, Hong Kong and the United Arab Emirates (UAE).

In the summer of 2020, the scheme Plahotniuc built over the years was taken over by two Bulgaria-registered companies that appeared overnight.

These companies were the identical financial offshore vehicles through which Plahotniuc, former leader of the PD, raised alleged dividends from the auctions organised by the state telecom company Moldtelecom, the purchase of electricity from the breakaway region of Transnistria, the public-private partnership for hemodialysis services and the so–called heist of one billion US dollars from the Moldovan banking system.

The Lithuanian UAB (an acronym of uždaroji akcine bendrove, or private limited company) started supplying blank cards for Moldovan passports following tenders in 2014 and 2017. The main beneficiary of the Garsu Pasaulis company is Albert Mario Karaziwan, a Belgian citizen who owns Semlex Europe, an identification document and biometric device production company whose business practices have come under scrutiny. The Syrian-Belgium businessman has been targeted in several countries in criminal corruption cases and journalistic investigations by Reuters and OCCRP.

In 2014, Moldova’s minister of information and communications technology was Plahotniuc’s fellow party member Pavel Filip. The CRIS Registru state enterprise which in 2017 was re-organised as ASP, was headed by Sergey Railean, godfather of Filip's older son.

Between 2014 and 2021, ASP transferred 59.5 million euros to the Garsu Pasaulis company "for raw material, blank cards and personalisation services," according to documents obtained by Black Box.

ASP also paid the Lithuanian company a royalty fee for software developed for Moldova and used on three types of documents. For example, the royalty fee for each passport issued was 13.61 euros (14.49 US dollars). On October 22, 2021, prosecutors opened a criminal case against nine people from the Public Services Agency “targeted in a criminal case of abuse of office”. Prosecutors estimated that the state lost around 41 million euros (43.6 million dollars) in the case.

A LONG AND TANGLED PATH

A note from the Moldovan service for the Prevention and Combating of Money Laundering obtained by Black Box shows that more than 24 million euros (25.54 million dollars) did not stop in the company's accounts in Vilnius but ended up in Cyprus and the UAE.

“Of the 135 payments made throughout this period [2014-2019], I can tell you that the final beneficiary is obvious. At least, from what the criminal investigation bodies say, it is clear that the actual beneficiary is Vladimir Plahotniuc,” said ASP director Mircea Esanu.

Sergey Railean, the ASP former director under whose mandate the two contracts with Garsu Pasaulis were signed, said that he knew nothing about benefits for Plahotniuc.

"The tender took place according to the procedures. Therefore, nothing was outside the law," Railean said.

Told that Black Box reporters had established money transfers from Garsu Pasaulis to offshore companies affiliated with Plahotniuc, Railean was asked if he knew anything about it.

"No, absolutely not. Now it is a criminal case. The file must be completed after the trial,"he said. “[…] We did not order any software."

Railean added that ASP paid royalty fees to Garsu Pasaulis "because that was the contract".

On May 5, 2022 the Moldovan anti-corruption prosecutor's office announced that Railean had the status of accused in the so-called passport affair.

Filip, who held the post of prime minister in 2016-2019, did not answer the phone calls or requests for comment.

In May 2018, during a TV show broadcast by Prime, one of Plahotniuc's TV stations, Filip hinted that the state signed a more advantageous contract with Garsu Pasaulis than the previous one agreed in 2011 with a French company.

In 2011, Garsu Pasaulis had in fact tried to win a tender, but its application failed as it did not meet ASP’s criteria. A key condition was that applicants had experience manufacturing electronic passports for at least three European countries, as established by a decision of the Supreme Court of Justice. Garsu Pasaulis did not meet this requirement.

Garsu Pasaulis replied via e-mail that the company won the tenders and successfully delivered blank passport cards for ASP.

“As for the exact details of other commercial contracts, we cannot provide any details as confidentiality commitments bind us,” Andrius Lukosevicius, director of Garsu Pasaulis’ printing security department, wrote. “However, we can confirm that we have never had and do not currently have commercial or other relations with Mr Plahotniuc and [Romanian businesswoman] Mrs Ileana-Mihaela Burcea.”

The passport cash headed south, to the UAE firm Prime Union Solutions FZ LLC. Between January 1, 2018 and July 30, 2019 itreceived transfers for over 4.7 million euros ( five million dollars) from Garsu Pasaulis. The money continued to flow into Plahotniuc's coffers even after he fled Moldova in June 2019 when his name was linked to the disappearance of over a billion dollars - nearly one-eighth of Moldova's GDP - from the country's biggest banks between 2012 and 2014.

Employees at the Moldovan Money Laundering Prevention and Combating Service obtained information from their colleagues in Dubai and stated that the company's majority shareholders were the Romanian citizen Ileana-Mihaela Burcea and the company Inter Gnathonize Limited.

Between October 29, 2018, and July 30, 2019, a total of seven million euros (about 7.4 million dollars) were credited into Prime Union Solutions’ UAE bank account, largely sent from Garsu Pasaulis. The money then traveled to Burcea’s private account in UAE and six other offshore companies.

In liaison with UAE and Cyprus’ authorities, Moldova’s law enforcement agencies determined that Garsu Pasaulis transferred another 19.6 million euros (20.8 million dollars) to another Cyprus offshore company, Gnathonize Limited, also connected to Burcea.

The Cypriot firm opened a bank account in July 2014, four months after Garsu Pasaulis won the Moldova tender. The Lithuanian firm was the main contributor to the account until August 2018. After that, the money was transferred to the company Prime Union INC LTD in Hong Kong and marked as a "dividend payment".

Part Two

Documents from the Hong Kong public registry show that Burcea was one of Prime Union’s shareholders and in 2014-2019 the director. In 2020, Burcea requested the closing of the company. In 2018, over 600,000 euros (639,000 dollars) were transferred from one of Prime Union’s bank accounts to another offshore in Gibraltar.

In addition, 1.5 million euros (1.6 million dollars) arrived in Burcea`s personal account in the UAE and almost 800,000 euros (852,600 dollars) were directed to Recon Business Data Service, a company registered in Dubai led by Burcea. The company was closed in December 2019.

Burcea’s lawyer Cristina Savulescu declined to comment on the financial transfers from Garsu Pasaulis to her client. She also did not comment on Burcea’s connection with Plahotniuc. Savulescu said that any association of her client with an alleged criminal case was damaging to her client's image.

"The judicial procedure in any criminal case, from the time of notification to the competent bodies until the time of sending a particular person to court, is non-public and confidential, meaning that third parties cannot know the content of the carried-out procedures," Savulescu said.

Documents obtained by Black Box with the support of the OCCRP network of investigative journalists show that Plahotniuc used the same infrastructure of offshore companies to take yet more funds out of Moldova.

The former politician used the offshore network for the money obtained from other auctions organised by state enterprises including Moldtelecom, Moldova’s largest telecommunication operator, gas supplier Energocom and the health ministry for dialysis-related services.

The UAE’s Recon Business Data Services, connected to Burcea, was also involved in the financial circuit of money leaked by Plahotniuc from another scheme related to Moldtelecom, concerning public tenders won by Bass Systems SRL in PD`s ruling period.

Between March 2017 to January 2019 the Chisinau-based IT company delivered technical equipment and services for Moldtelecom worth about 41 million euros (43.6 million dollars). Out of this amount, eight million euros (8.5 million dollars) and six million dollars followed the same route to the UAE through Recon Business Data Services.

OFFSHORE ACCOUNTS

Another document obtained from the Moldovan service for the Prevention and Combating of Money Laundering shows that the Dubai-based company made several transactions to two offshores used by Plahotniuc: the UAE-based Vanguard International LTD and Vanguard International Group, registered in Samoa.

Both companies appeared in Plahotniuc's wealth statements in 2018. However, in the document submitted to Moldova’s Central Electoral Commission on the eve of the February 24, 2019 parliamentary elections, the oligarch declared 4.5 million euros (4.78 million dollars), over 11 million lei (around 585,000 dollars) and 347,000 dollars as dividends obtained from the Dubai-based Vanguard International Ltd.

Moldovan prosecutors established the origin of the money collected by Plahotniuc as "dividends".

Vanguard International LTD received 8.2 million euros (8.72 million dollars) and 2.5 million dollars from UAE-registered RECON SPC LIMITED from December 2017 to May 2019.

Burcea and another Romanian citizen, Silviu Tutuianu, were behind the company in different periods. Almost the entire amount came from the other similarly named firm, the Dubai-based Recon Business Data Service.

Plahotniuc also collected "dividends" worth 1.7 million euros (1.80 million dollars) and almost 350,000 US dollars through another offshore company, TGME INVESTMENTS SPC LTD, managed by Tutuianu.

All these companies were liquidated between the end of 2019 and the beginning of 2020, after Plahotniuc fled Moldova. The Moldovan anti-corruption prosecutor's office opened a case for the purchase of equipment and services by Moldtelecom from SRL Bass Systems. The prosecutors confirmed that Burcea was interviewed in this criminal case, but did not disclose her status.

Burcea also managed a company that benefited from transfers from Plahotniuc’s Cyprus-registered Asia Pacific Textile Limited. This had transactions with the Cypriot offshore Melopmania Limited, the founder of BB-Dializa, a company which managed the dialysis services for the Moldovan health ministry.

BB Dializa also benefited from legal services from Cyprus-registered Kinanis offshore, founded by Burcea. The company also provided secretarial and legal services for Assentis Holdings Limited, one of the founders of Bass Systems SRL.

Asia Pacific Textile LTD received money from the Energokapital shell company. Between 2014 and 2016, the firm was used by Plahotniuc and Evgheni Shevciuk, former leader of Moldova’s breakaway region of Transnistria, to sell the electricity produced by the Russian-owned Moldgres Power Plant to Moldovan consumers.

The Black Box team tracked Energokapital's connections with Plahotniuc and the involvement of former DP deputy Vladimir Andronachi in the company's management.

Moldova’s service for the Prevention and Combating of Money Laundering established the connection between Burcea and two other offshore companies involved in looting a billion dollars from the country’s banking system: Sharp Prospects Limited and Lazomar Trading Limited, registered in Hong Kong and Cyprus respectively.

According to an international independent financial audit named the Kroll report, the Lazomar company received 5.6 million dollars in transfers to a Cypriot bank account. The Kroll report was commissioned by the National Bank of Moldova to investigate the theft that ravaged the country’s banking system.

Plahotniuc did not respond to requests for comment. His lawyer Lucian Rogac said that the former politician pleaded not guilty in the case generically called "blank passport cards".

"An indictment was presented to us. Other evidence to prove guilt was not shown by the prosecution. The only comment I can give you is that my client pleads not guilty to the charges," Rogac said.

In September 2022 Plahotniuc received an arrest warrant in absentia regarding the "blank passport cards" case, alongside Vladislav Zara, former director of the civil registry ASP, ex-PD deputy Andronachi and businessman Alexandru Vilcu. All of them have fled the country. According to Moldova’s ministry of justice, Plahotniuc is currently in Northern Cyprus.

Part Three

The scheme was taken over in the summer of 2020 by two Bulgarian companies.

In May 2020, the Lithuanian company UAB Garsu Pasaulis transferred the right for using the blank cards software to Optimo Service Ltd in Bulgaria, which ASP had co-opted to manage the documents’ personalisation programme.

"ASP proposed to have a third party take over the maintenance of the software from us. At the same time, we received proposals for cooperation from Optimo in Bulgaria," Garsu Pasaulis’ executive Andrius Lukosevicius said in a statement.

"Therefore, we wanted to avoid having any direct relationship with Optimo. While ASP persisted with its complaints [about improper maintenance of the software], we proposed to the client [ASP] that it consider entering into an agreement with Optimo (without us being involved in such a relationship) whereby Optimo would take over the software from us and its maintenance. We would no longer be responsible for this," he concluded.

Headquartered in Sofia’s luxury district of Manastirski Livadi, Optimo Service Ltd was founded on November 27, 2019, half a year before taking over the right to manage the software from Garsu Pasaulis. The founder is Russian citizen Sergey Pirojkov, while the manager is Bulgarian citizen Tsvetan Stoyanov Dimitrov.

The Bivol Investigative Journalism Centre reporter in Bulgaria, one of Black Box's partners in this investigation, went to the company's headquarters to talk to the owners. According to the documents detailing the company’s address, the offices are on the top floor of a residential building, where a beauty salon is also located. There is no plaque indicating the presence in this location of businesses involving ASP and Garsu Pasaulis.

In November 2022, a Bivol reporter knocked on the door. An employee of the beauty salon opened it and said that at the end of the corridor there was an office where "two Russian guys are working on computers, Serioja and Anton". The two men "rarely come to work".

On October 26, 2020, Optimo Service transferred its commitments to ASP to another Bulgarian company, Optimo IT Solutions LTD, whose owner is none other than Stoyanov, Optimo Service’s manager.

Two weeks before this deal, Stoyanov bought an older company and changed its name to Optimo IT Solutions.

Almost two months after Stoianov’s take over, the ASP funds began to flow into the accounts of Optimo IT Solutions as royalty fees for delivering the IDs and passports

According to documents seen by the Black Box team, between November 24, 2020, and August 13, 2021, ASP made 19 payments totaling 5.6 million euros (5.96 million dollars), to the newly established Optimo IT Solutions LTD.

The director of ASP, Mircea Esanu, told Black Box about the shady software rights transfer to Bulgarian companies.

"I assume who is [the beneficiary of those companies]. I have yet to see documents demonstrating where the money went from those accounts of the Bulgarian companies. But for me, it is strange when a company, even a printing house, sells practically for free to a Bulgarian company created overnight and later collects 5.6 million euros (5.96 million dollars) for a year,” he said.

On the same day in November 2022, the Bivol reporter returned to Optimo IT Solutions’ offices in central Sofia, to talk to the company's owner. The office is in an old building and access to the courtyard is prohibited. Employees of the company providing the space for rent refused to grant allow the reporter inside the building. The accountant of the same company refused to give any details.

Black Box called Optimo IT Solutions headquarters to talk to Stoyanov. The company secretary said to send questions by e-mail, but reporters did not receive an answer.

NEW MANAGEMENT

Returning to the summer of 2020, Optimo Service took over the royalty scheme. One month after transferring the rights to the document personalisation software, the Bulgarian company decided to take a Moldovan partner to represent its interests with ASP.

The company wrote to ASP that IT-LAB GRUP SRL would manage the software. The connections led to the Moldovan businessman Alexandru Vilcu.

According to the letter sent to the ASP by the Bulgarian company, IT-LAB GRUP was to deal not only with the technical servicing of the software but to also manage the entire business administration process.

Furthermore, the Moldovan business would be allowed to hold the Optimo Service company stamp, sign documents, and receive and make payments on behalf of the Bulgarian enterprise.

In November 2022, the founder of IT-LAB GRUP, Alexey Cioban, told Black Box that he did not provide any services to ASP because he no longer cooperated with the Bulgarian company. He claims that he was contacted directly from Sofia but did not say with whom he negotiated.

"We had some discussions about a potential partnership. I also went to ASP, and we discussed concluding a contract, but [we did not], with neither ASP nor the Bulgarian company. We did not reach an agreement. We didn't do any work. We didn't get any money and wanted to avoid collaborating with this company [Optimo],” Cioban said. "We had to take care of the technical part, the software, and the equipment installed at ASP. I talked with ASP, found out more details, and said it differs from our line of work. We refused."

Documents however show that the partnership between Optimo Service and IT-LAB lasted half a year and their collaboration contract was terminated in January 2021.

Cioban's firm, delegated by the Bulgarians to defend their interests in Moldova, has its legal address in Chisinau’s Rascani neighbourhood. According to the land registry, the building in which IT-LAB operates belongs to Tehnovin, a machinery manufacturing company owned by Vilcu.

Cioban categorically denied he ever collaborated with Vilcu in the business of Moldova’s public service agency.

In an exchange of messages with Black Box, Vilcu admitted that he tried to arrange a partnership with the company from Bulgaria and proposed a collaboration with IT-LAB. This contradicts Cioban, who denied his partner's involvement in the ASP case.

"We tried with Alexei [Cioban] to partner with those from Lithuania, but after an analysis, Alexei understood that he would not be able to cope with this and refused. And there, believe me, there was no mention of the figures I read in the files and the press,” Vilcu said.

He added it was a "decent proposal for Moldova," about "tens of thousands, not millions".

In September 2020, Vilcu received an arrest warrant in absentia; he did not appear at the hearing as requested by prosecutors.

Vilcu denies allegations that he was one of the beneficiaries of the ASP scheme and claims he initiated his own investigation to find out who benefited from the money stolen from the passports.

"I want to assure you that I did not participate in this affair. I had nothing to do with passports or other documents from Moldova. I have never dealt with a business that is outside the law. I was less interested in the Bulgarian company. I was more interested in the documents based on which the criminal file was opened against me," Vilcu said.

MULTIPLE CONNECTIONS

Another character targeted in the passport blanks case was the former deputy Vladimir Andronachi.

The anti-corruption prosecutor's office has established connections between the Bulgarian companies Optimo Service and Optimo IT Solutions with Andronachi and relationships with businessman Alexandru Vilcu.

The prosecutor's office stated that it is verifying Andronachi and Vilcu’s involvement in the ASP scheme.

“We inform you that a preliminary link of connection has been established between these natural and legal persons, but the criminal prosecution body still verifies the factual circumstances of these links. In this sense, requests for rogatory commissions are to be formulated," the statement read.

An official source said that the connection between Andronachi and the companies in Bulgaria was ensured by his family’s lawyer, Carolina Andriuta, who allegedly managed the Bulgarian companies from Chisinau. Black Box reporters have not been able to independently verify these allegations.

The anti-corruption prosecutor's office confirmed that Andriuta is accused in the criminal case “for complicity in the abuse of office and money laundering” but stated that the investigation continues.

Andriuta managed several companies connected to Andronachi. Currently, she is on the accused bench in a case concerning bank fraud, together with Nadejda Andronachi, Vladimir Andronachi’s wife.

Oleg Mita, Vladimir Andronachi’s lawyer, who was recently detained in Ukraine and extradited to Moldova on November 2, 2022 did not respond to questions.

Andronachi remains in prison and Mita states that he pleads not guilty in the “passport affairs” case.

"Mr Andronachi had been officially charged in this case. But he does not admit his fault. He explained to the prosecutors that he knew nothing about such actions related to so-called passport forgery schemes," the lawyer said.

Mita is also Carolina Andriuta's lawyer. Mita claims that Andriuta was not accused and also pleaded not guilty.

Melvin Kramer

[bhushans]

Global Focus on Improved Outcomes: Global Hemodialysis and Peritoneal Dialysis Market

The global hemodialysis and peritoneal dialysis markets is ready to change and have a lasting influence that lasts well into 2034 and beyond. Hemodialysis and peritoneal dialysis are expected to cost a combined USD 104.3 billion by 2024. The market is anticipated to be worth more than USD 245 billion by 2034.

Hemodialysis and peritoneal dialysis are predicted to grow at a strong 8.9% CAGR until 2034.

Enhance Research With a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14681

Key Highlights:

Strong Regulatory Framework and Healthcare Infrastructure: North America’s hemodialysis and peritoneal dialysis market is benefiting from the region’s stringent regulatory standards and advanced healthcare infrastructure. Regulatory compliance ensures patient safety and quality of care, while state-of-the-art facilities and technologies facilitate the delivery of effective dialysis treatments.

Rising Prevalence of Renal Diseases: The increasing prevalence of renal diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is driving the demand for hemodialysis and peritoneal dialysis treatments. Factors such as aging populations, lifestyle-related risk factors, and improved diagnostic capabilities contribute to the growing burden of renal conditions, necessitating expanded dialysis services.

Technological Advancements and Innovation: Technological advancements in hemodialysis and peritoneal dialysis modalities are enhancing treatment efficacy, patient comfort, and convenience. Innovations such as wearable dialysis devices, home-based dialysis solutions, and remote monitoring systems are reshaping the dialysis landscape, empowering patients to manage their condition more effectively and improve their quality of life.

Focus on Personalized and Value-Based Care: The shift towards personalized and value-based care models is driving the adoption of tailored dialysis regimens that optimize patient outcomes and resource utilization. Integrated care approaches, multidisciplinary care teams, and patient-centered initiatives aim to address the holistic needs of individuals with renal diseases, promoting better health outcomes and cost-effective care delivery.

Key Takeaways : 

In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.

With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.

The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.

China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.

By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.

COMPETITIVE LANDSCAPE: 

The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).

RECENT DEVELOPMENT: 

Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.

Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.

Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.

KEY SEGMENTS:

By Type:

Hemodialys

Peritoneal dialysis

By End Use:

Hospital Based

By Product:

Device

Consumables

Services

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

[markettrendsus]

Kidney Dialysis Market: Size, Share, Growth and Forecast 2032

The Global Kidney Dialysis Market is expected to reach a value of USD 83.4 billion in 2023, and it is further anticipated to reach a market value of USD 143.8 billion by 2032 at a CAGR of 6.2%. Kidney dialysis is a procedure used to remove waste and excess fluid from the blood when the kidneys are unable to perform this function properly. The increasing prevalence of chronic kidney diseases, rising healthcare expenditures, technological advancements in dialysis products and growing geriatric population are major factors driving the growth of the kidney dialysis market.

Drivers of the Kidney Dialysis Market

The rising incidence of kidney diseases is a major driver for the kidney dialysis market. Diabetes and hypertension are the leading causes of kidney disease. With rising rates of obesity and diabetes, more people are developing chronic kidney diseases. According to the Centers for Disease Control and Prevention (CDC), 15% of US adults are estimated to have chronic kidney disease.

The growing geriatric population is another key driver for the market. Older people are more prone to acute and chronic kidney diseases. The UN estimates that the global population aged 60 years or over will grow by 56% between 2020 and 2030. This expanding pool of geriatric population will drive the demand for dialysis.

Technological advancements and new product launches by leading players are also fueling the growth of the kidney dialysis market. Companies are focusing on developing advanced dialysis machines and dialyzers to improve efficiency and patient outcomes. The integration of connected technologies such as remote monitoring is also driving market growth.

Request For Sample: https://www.dimensionmarketresearch.com/report/kidney-dialysis-market/requestSample.aspx

Segments of the Kidney Dialysis Market

Hemodialysis Segment

The hemodialysis segment held the largest share of the market in 2022. Hemodialysis is the most common modality used by patients with chronic kidney disease. The rising incidence of End Stage Renal Disease (ESRD), favorable reimbursement policies, and availability of advanced hemodialysis products are driving this segment.

Peritoneal Dialysis Segment

Peritoneal dialysis is projected to register the highest CAGR during the forecast period. It offers greater flexibility to patients in terms of lifestyle and traveling. Technological developments in cyclers and connectology are also fueling the adoption of peritoneal dialysis.

In-center Dialysis Segment

In-center dialysis dominated the market in 2022 in terms of service providers. In-center dialysis provides monitoring by skilled staff during the entire treatment. The segment is driven by favorable reimbursement policies and the expanding network of dialysis centers globally.

Home Dialysis Segment

The home dialysis segment is expected to expand at the highest rate over the forecast period. Home dialysis offers increased flexibility and independence to patients. Rising awareness of home dialysis and introduction of innovative products by key players are propelling the growth of this segment.

Request For Sample: https://www.dimensionmarketresearch.com/report/kidney-dialysis-market/requestSample.aspx

Regional Analysis

North America accounted for the largest share of the global kidney dialysis market in 2022. High incidence of ESRD, established healthcare infrastructure, rising healthcare spending and presence of key players are driving the North America kidney dialysis market.

Asia Pacific is anticipated to grow at the fastest rate during the forecast period owing to the rising prevalence of diabetes & hypertension, increasing healthcare expenditure and expanding geriatric population in the region.

Key Players

Some major companies operating in the global kidney dialysis market include:

- Fresenius Medical Care - Baxter International Inc. - Nipro Corporation - B. Braun Melsungen AG - Nikkiso Co., Ltd - Becton, Dickinson and Company - Medtronic Plc - Asahi Kasei Corporation - Terumo Corporation - Renal Technologies Limited

These players are adopting strategies such as new product launches, mergers & acquisitions and geographical expansions to increase their share in the kidney dialysis market.

Future Outlook

The global kidney dialysis market is projected to continue its robust growth during the forecast period. The market will be driven by the rising burden of chronic kidney diseases, favorable government initiatives to increase access to dialysis, technological innovations and increasing geriatric population. Emerging markets in Asia Pacific and Latin America also present significant opportunities due to improving healthcare infrastructure.

However, the high cost of dialysis products and services limits access in developing regions. Stringent regulatory scenario also poses a challenge to market growth. Leading players operating in the market are investing in R&D to develop advanced and flexible dialysis systems to improve clinical outcomes and quality of life for patients. The future outlook for the kidney dialysis market remains positive driven by the rising patient population and technology progress.

Request For Sample: https://www.dimensionmarketresearch.com/report/kidney-dialysis-market/requestSample.aspx

Frequently Asked Questions

Q1: What is the global kidney dialysis market size?

A1: The global kidney dialysis market size was valued at $89.2 billion in 2022 and is projected to reach $136.1 billion by 2030.

Q2: What is driving the kidney dialysis market growth?

A2: Key factors driving kidney dialysis market growth include rising incidence of chronic kidney diseases, growing geriatric population, technological advancements in dialysis products and favorable government initiatives.

Q3: Which region dominates the kidney dialysis market?

A3: North America accounted for the largest share of the global kidney dialysis market in 2022. Rising prevalence of End Stage Renal Disease (ESRD), established healthcare infrastructure and presence of key players drive the North America market.

Q4: Who are the key players in the kidney dialysis market?

A4: Leading companies in the kidney dialysis market include Fresenius Medical Care, Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd., among others.

Q5: Which is the fastest growing segment in the kidney dialysis market?

A5: The peritoneal dialysis segment is projected to register the highest CAGR during the forecast period owing to flexibility, technological advancements in cyclers and connectology.

Q6: What is the future outlook for the kidney dialysis market?

A6: The global kidney dialysis market is projected to grow at a CAGR of 4.9% from 2023 to 2030, driven by rising burden of kidney diseases, favorable government policies, new product launches and increasing access to dialysis services globally.

Conclusion

The kidney dialysis market is poised for steady growth in the coming years driven by the rising incidence of chronic kidney diseases worldwide, expanding geriatric population, advancements in dialysis technologies and increasing healthcare expenditure. Key players are focusing on developing innovative dialysis systems and expanding their geographic presence to tap growth opportunities.

The rising adoption of home dialysis presents a significant opportunity for manufacturers. At the same time, high costs of dialysis remain a challenge, especially in developing regions. Going forward, increasing awareness programs, favorable reimbursements and government funding initiatives will help increase access to dialysis therapy for patients worldwide. Market players need to focus on emerging economies which present immense growth potential owing to the large patient base and improving healthcare infrastructure.

[hiranandanihospitalpowai]

The benefits of getting kidney care at Dr L H Hiranandani Hospital

Hiranandani Hospital is a multi-specialty healthcare center based in Powai, Mumbai. Dr L H Hiranandani is the learned soul behind this brilliant healthcare project. And today, the hospital is serving influentially in the metro city with more than 240 operational beds.

Dr Sujit Chatterjee, CEO - Dr L H Hiranandani Hospital says, that he is dedicatedly working on bringing the best facilities and quality care related to kidney diseases and kidney failure in the department. His good work is carried with concern, and respect for every patient which is the support system of this entire hospital. The hospital is actively associated with the mission to deliver the best quality and affordable healthcare services to the citizens of India through skilled doctors and an interactive business model. In aggregate, the hospital provides advanced levels of care in more than 20 specialties, including cancer care, orthopedics, human reproduction, bariatric surgery, nephrology, critical care, cardiology, gynecology, physical rehabilitation, neurology and others.

Dr L H Hiranandani Powai Hospital is a renowned multispecialty hospital in Mumbai, India, that offers a wide range of medical services, including kidney treatment. Here are some reasons why it is the best place to get kidney treatment:

•  It has a dedicated Centre for Renal Sciences that provides comprehensive care for patients with kidney diseases and disorders. The center offers advanced diagnostic and therapeutic facilities, such as kidney biopsy, dialysis, peritoneal dialysis, hemodialysis, continuous renal replacement therapy (CRRT), and kidney transplantation.

•  It has a team of highly qualified and experienced nephrologists, urologists, transplant surgeons, anesthetists, nurses, and technicians who work together to provide the best possible care for the patients. The team follows international standards and protocols to ensure quality and safety.

•  It has a state-of-the-art kidney transplant unit that performs both live and cadaveric donor kidney transplants. The unit has a dedicated transplant ICU with modern equipment and facilities to monitor and treat the patients after the surgery. The unit also has a transplant coordinator who guides and counsels the patients and their families throughout the process.

•  It has a patient-centric approach that focuses on providing holistic care for the patients and their families. The hospital offers various services and amenities to make the patients comfortable and satisfied, such as 24/7 emergency services, online appointments, health check-ups, health insurance, pharmacy, cafeteria, library, prayer room, and free Wi-Fi.

•  It has received several awards and accolades for its excellence in kidney treatment, such as the Best Hospital for Nephrology in India by Times Health Survey 2020, the Best Hospital for Renal Transplant in India by India Healthcare Awards 2019, and the Best Hospital for Nephrology in Mumbai by Times Health Survey 2019.

[research--blog]

Home Healthcare Market to be Worth $514.5 Billion by 2030 - Exclusive Report by Meticulous Research®

 According to a new market research report titled, ‘Home Healthcare Market by Offering (Fertility, Pregnancy, Cholesterol Tests, Oxygen Delivery, Dialysis, IV, Patient Support Equipment), Services (Rehabilitation, Telehealth, Nursing, Hospice), Application (Cardiovascular, Diabetes)- Global Forecast to 2030,’ published by Meticulous Research®, the home healthcare market is projected to reach $514.5 billion by 2030, at a CAGR of 7.9% from 2023 to 2030.

Population aging is the dominant demographic trend of the twenty-first century—a reflection of increasing longevity, declining fertility, and the progression of a large number of individuals to older ages. The OECD forecasts that, globally, the population aged 60 and over is expected to reach 2.1 billion by 2050. As per the World Health Organization (WHO) statistics, the global population in the age group of 60 years and above was expected to increase from 1 billion in 2020 to 1.4 billion in 2022. The growth in the aging population has resulted in the increased adoption of home healthcare services due to the high costs of hospital healthcare services.

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=1280

The geriatric population is highly susceptible to diseases such as high blood pressure, diabetes, arthritis, and cardiovascular diseases. Therefore, the growing global geriatric population, coupled with the fact that approximately 70% of home health patients belong to the age group of 65 years and above, is expected to drive the demand for home healthcare products and services during the forecast period.

Impact of COVID-19 on the Home Healthcare Market

The COVID-19 pandemic positively impacted the home healthcare market. The pandemic has increased the preference for home healthcare due to the risks of acquiring infections during hospital and clinic visits for treatment and related purposes. The pandemic has also increased the adoption of telehealth, making it a primary source of care for many patients. According to the 2021 World Economic Forum’s 5G Outlook Series report, there has been an increase of 490% in telemedicine visits for urgent cases. Furthermore, the outbreak of the COVID-19 pandemic increased the demand for home healthcare infrastructure and increased investments from governments in promoting homecare services. For instance, in August 2022, Fresenius Medical Care North America, the North American division of Fresenius Medical Care AG & Co. KGaA (Germany), acquired Interwell Health U.S. This acquisition was aimed at bringing Fresenius Health Partners’ expertise in kidney care and value-based performance and contracting.

The home healthcare market is segmented based on Offering (Home Tests and Patient Monitoring Equipment [Fertility Tests & Aids, Pregnancy Tests, Gender, DNA, and Parental Tests, Cholesterol Tests, HIV Tests, Holter Monitors, Blood Pressure Monitors, Oximeters, Heart Rate Monitors,

Thermometers, Stethoscopes, Defibrillators, Pedometers, Scales & Body Fat Monitors, Peak Flow Meters, Apnea Monitors, Baby Monitors, Coagulation Monitors, Diabetes Management]), Home Therapeutic Equipment ({Home Respiratory Therapy Equipment, [Continuous Positive Airway Pressure Equipment (CPAP Machines, CPAP Accessories & Consumables)], Oxygen Delivery Equipment, Nebulizers & Accessories, Ventilators & Accessories}, Home Dialysis Equipment, {Home Peritoneal Dialysis Products, Home Hemodialysis Products}, Home IV Equipment {IV Pumps, Other Home IV Equipment}, Other Equipment), Patient Support Equipment, {Mobility Assist Equipment, [Wheelchairs], Walking Assist Devices {Walking Assist Devices, [Walkers and Rollators, Canes & Walking Sticks, Crutches], Mobility Scooters, Medical Furniture and Accessories, Bathroom Safety Equipment), Services (Rehabilitation Services, Infusion Services, Skilled Care/Nursing, Unskilled Care Services, Telehealth Services, Hospice Care Services, Respiratory Therapy Services, Other Services), Application (Cardiovascular Diseases & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Cancer, Wound Care, and Other Applications) and Geography. The study also evaluates industry competitors and analyzes their market shares at the country and regional levels.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business : https://www.meticulousresearch.com/speak-to-analyst/cp_id=1280

Based on offering, in 2023, the home therapeutic equipment segment is expected to account for the largest share of the home healthcare market. The growth of this segment is attributed to increasing cases of chronic kidney and respiratory diseases, the high costs of therapeutic services in hospitals, and the availability of rental products, including ventilators, nebulizers, and oxygen delivery equipment.

Based on services, the skilled care/nursing segment is projected to register the highest CAGR during the forecast period. The growth of this segment is attributed to the wide range of daily tasks performed by nurses to provide adequate care for patients receiving homecare, the rising adoption of home-based treatments that require technical knowledge of operating healthcare products which includes home dialysis equipment, and home IV equipment, home respiratory therapy equipment, and the increasing demand for home care for the elderly population.

Based on application, in 2023, the diabetes segment is expected to account for the largest share of the home healthcare market. The growth of this segment is attributed to the rising number of diabetic patients globally who are more prone to diseases such as cardiovascular diseases and Alzheimer's disease. Furthermore, the growing need to monitor the heart rate, hemoglobin, cholesterol, and blood pressure levels of diabetic patients contributes to the growth of this market segment.

“Exciting news! We are thrilled to announce an incredible opportunity for you!

For a limited time only, we are delighted to offer an exclusive flat 30% discount on all our remarkable research reports. It's our way of showing appreciation for your continuous support and commitment to staying informed. This remarkable discount allows you to unlock a wealth of valuable insights and expert analysis at an unbeatable price. Whether you're a business professional, an academic researcher, or an avid learner, this offer is tailor-made to enhance your knowledge and empower your decision-making.”

Quick Buy – Home Healthcare Market - Global Opportunity Analysis And Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/85264114

Based on geography, in 2023, North America is expected to account for the largest share of the home healthcare market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest shareholding market in North America. The market growth in the U.S. is attributed to the high disposable incomes of the population, the rising number of patients with chronic diseases, and government investments in promoting home healthcare.  However, Asia-Pacific is expected to witness a rapid growth during forecast period. The growth of this regional market is attributed to the increasing geriatric population, the rising prevalence of chronic diseases in developing nations, the increasing investments in home healthcare in developing countries such as China and India, and the higher preference for home-based treatments due to the high costs of hospital services. Furthermore, government initiatives promoting homecare and the launch of advanced homecare products are driving the growth of the home healthcare market in Asia-Pacific.

The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the past three to four years. In the last couple of years, the home healthcare market has witnessed various developments.

Some of the key players operating in the home healthcare market are Abbott Laboratories (U.S.), Amedisys, Inc (U.S.), Owens & Minor (U.S.), B. Braun SE (Germany), Baxter International, Inc. (U.S.), BAYADA Home Health Care (U.S.), Convatec (U.K.), Halyard Health, Inc. (U.S.), Covidien (Ireland), Fisher & Paykel (New Zealand), Fresenius Medical (Germany), GE Healthcare (U.S.), Johnson & Johnson (U.S.), and F. Hoffmann-La Roche AG (Switzerland).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/home-healthcare-market-1280

Scope of the Report:

Home Healthcare Market, by Offering

Home Tests and Patient Monitoring Equipment

Fertility Tests & Aids

Pregnancy Tests

Gender, DNA, and Parental Tests

Cholesterol Tests

HIV Tests

Holter Monitors

Blood Pressure Monitors

Oximeters

Heart Rate Monitors

Thermometers

Stethoscopes

Defibrillators

Pedometers

Scales & Body Fat Monitors

Peak Flow Meters

Apnea Monitors

Baby Monitors

Coagulation Monitors

Diabetes Management               

Home Therapeutic Equipment

Home Respiratory Therapy Equipment

Continuous Positive Airway Pressure Equipment

CPAP Machines

CPAP Accessories & Consumables

Oxygen Delivery Equipment

Nebulizers & Accessories

Ventilators & Accessories

Home Dialysis Equipment

Home Peritoneal Dialysis Products

Home Hemodialysis Products

Home IV Equipment

IV Pumps

Other Home IV Equipment

Other Equipment

Patient Support Equipment

Mobility Assist Equipment

Wheelchairs

Walking Assist Devices

Walkers and Rollators

Canes & Walking Sticks

Crutches

Mobility Scooters

Medical Furniture and Accessories

Bathroom Safety Equipment

Home Healthcare Market, by Services

Rehabilitation Services

Infusion Services

Skilled Care / Nursing

Unskilled Care Services

Telehealth Services

Hospice Care Services

Respiratory Therapy Services

Other Services

Home Healthcare Market, by Application

Cardiovascular Diseases & Hypertension

Diabetes

Respiratory Diseases

Pregnancy

Mobility Disorders

Cancer

Wound Care

Other Applications

Home Healthcare Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

Italy

U.K.

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=1280

[missionarynurse]

I’m Nurse Assistant at Medical Center Taguig.

Assigned at Medical-Surgical Ward and Emergency Room. 

Rotated at Hemodialysis Unit and Operating Room. 

(November 2019 - July 2020) 

Main Reason why I allowed myself to be NA while my other classmates are already RN? 

“sobrang sakit na wala pa akong pambayad ng tuition fee balance ko. 

sobrang sakit na hindi ko naipasa ang course audit in my last year of nursing school.”

but I continued achingly, 

I still dream anyway.

I look forward to be the Head of Nursing Division someday.

I want to be in the grass roots. 

I want to be involved with the unnoticed workers of the hospital.

I still love anyway.

I still care anyway.

https://www.instagram.com/stories/highlights/17895169744409900/

[aishavass]

In 2018, North America dominated the global hemodialysis and peritoneal dialysis market by contributing over 36% and is anticipated to maintain its market...

[lupine-publishers-juns]

Lupine Publishers | Reasons and Outcome of Patients after Permanent Transfer from Peritoneal Dialysis to Hemodialysis: A Review of 16 years of Experience in Senegal

Abstract

Introduction: Peritoneal dialysis (PD) and haemodialysis (HD) are two complementary and non-competitive renal replacement therapy (RRT). A patient can be transferred from one technique to the other. The objective of this study was to assess the reasons for transferring patients from PD to HD and to follow their outcome. Patients and Methods: This is a 16-year descriptive and analytical retrospective study (March 1, 2004 - August 31, 2020) conducted at the PD unit of the Aristide Le Dantec University Hospital in Dakar. Were included, patients on PD for at least 30 days, over 18 years of age and permanently transferred to HD. The probability of survival for any duration of post-transfer follow-up was estimated by the Kaplan-Meier method. Results: The analysis covered 98 out of 113 cases. The mean age of the patients was 45.2 ± 14.09 years at the initiation of PD and 47 ± 13.91 years at the time of transfer, with a sex ratio of 0.66. The mean duration in PD was 19.9 ± 17.25 months [range, 1.0-90.0 months]. The transfer to HD concerned 73.5% of patients in the first two years. The reasons for transfer were mainly associated with infection (82.7%), mechanical complications (23.5%), social reasons (12.2%) and inadequate dialysis (6.1%). It was programmed in 11.4% of cases and 6% of patients had a permanent approach. At the endpoint date, the mean duration in hemodialysis was 43.3 months with 42.8% of patients still in HD. There was a kidney transplant patient; a return to PD. Mortality was 34.6%. The mean HD survival was 126 months. There was a statistically significant relationship between infection as a reason for transfer and mortality (p = 0.047). Conclusion: The main reasons for transferring PD to hemodialysis identified in the literature are found in our context. This transfer must be anticipated to reduce morbidity and mortality.

Keywords: Peritoneal dialysis; Transfer of Patients; Peritonitis

Introduction

Peritoneal dialysis (PD) and haemodialysis (HD) are two complementary modalities of renal replacement therapy. There is an increasing use of PD in the world, with a prevalence multiplied by 2.5 between 1997 and 2008 [1]. Indeed, this technique has shown survival rates similar to HD [2] or even better [3]. The main limitations of PD are related to the failure of the technique, forcing patients to switch to HD [4]. In the 2010 ANZDATA (Australia and New Zealand Dialysis and Transplant) report, 20% of PD patients were definitively transferred to HD [5]. Similar rates have been reported in other countries [6]. According to the REIN registry, each year 10% of patients in PD are transferred to HD, mainly during the first two years of treatment [7]. The most common causes of technique failure are peritoneal infection, inadequate dialysis, catheter dysfunction or patient choice [8-10]. In addition, the risk of transfer to HD is relatively high during the first 6 months of the onset of PD [8,9]. Several risk factors for PD technique failure have been identified. They include advanced age, high permeability of the peritoneal membrane, reduced peritoneal ultrafiltration, malnutrition, diabetes, and increased body mass index [8-11]. In Senegal, there is little or no data available that has examined the reasons for transfer and the outcome of patients transferred from PD to HD. This is why we conducted this work in order to assess the reasons for transferring patients from PD to haemodialysis and to monitor their future on haemodialysis.

Patients and Methods

This was a descriptive, analytical and multicenter retrospective study over a period from March 01, 2004, to August 31, 2020. Were included, all patient in PD for at least 30 days, over 18 years of age and permanently transferred to HD. The data were collected on an operating sheet, from the medical files. Epidemiological data: existence of comorbidities at the start of PD and at the time of transfer to HD (the Charlson comorbidity score [12] was calculated retrospectively at the initiation of PD and at the start of treatment with HD); the stay in PD and entry into HD were analyzed. As of the August 31, 2020, point date, we have also collected the following parameters: a) Haemodialysis parameters: weekly number and duration of HD sessions, mean inter-dialytic weight gain over one-week, average dialysis dose over one week, type of vascular access: b) For the outcome of the patients: a. Duration in HD. b. Status: deceased, kidney transplant returned to PD, still in HD or lost to follow-up. c. If death: date / year, cause. d. If returned in DP: reasons.

Results

Ninety-eight (98) were included in the study. The mean age at initiation of PD was 45.17 ± 14.09 years. At the time of transfer the mean age was 47.00 ± 13.91 years. There was a female predominance with a sex ratio of 0.66. The initial nephropathy was undetermined in 29.6% of cases. Nephroangiosclerosis and chronic glomerulonephritis of undetermined origin accounted for 28.6% and 15.3% respectively (Table 1). Forty-nine (49) patients received hemodialysis before access to PD. At the initiation of PD, high blood pressure was the most common medical history (94.90%), followed by diabetes and a history of cardiovascular disease (8.16%). The mean Charlson’s index was 2.88 ± 1.31. The mean distance traveled to reach the PD unit was 68.62 ± 104.61 km. The mean length of stay in PD was 19.94 ± 17.25 months. Seventy-two (72) patients were transferred during the first two years of PD. The majority of patients had infectious complications (92.85%) (Table 2) and 59.18% of cases had mechanical complications (Table 3). The main reason for transfer was infection (82.7%), followed by mechanical causes (23.5%) and social reasons (12.2%) (Table 4). There was a statistically significant relationship between infection as a reason for transfer and mortality (p = 0.047). Transfer was program in 9 patients (11.4%). The vascular access at the first haemodialysis session was permanent in 6 patients. Twenty-seven (27) patients had a permanent vascular access after transfer. The mean time to have arterio-venous fistula was 6.46 ± 4.60 months. The mean duration on Haemodialysis was 43.29 ± 44.82 months.

Discussion

At the time of HD transfer, the mean age of transferred patients was 47.00 ± 13.91 years in our series, while it was 60.0 ± 14.2 years according to Chen et al. [13], and 68.6 ± 16.8 years according to Habib et al. [14]. Contrary to what is conventionally described in the literature, our transferred patients were younger. This can be explained by the reluctance of elderly patients to change modality, preferring to stay on PD rather than doing multi-weekly HD sessions. We can also assume that these older patients are transferred less frequently, as they die before an HD transfer is necessary. The mean PD duration was 19.94 ± 17.25 months, and the median was 15.50 months [1.0-90.0]. Habib et al. reported a mean duration of 25.9 ± 23.44 months, [14] and Panagoutsos et al. found a mean of 36 ± 16 months [15]. Ferreira et al. and Szeto et al. found a mean PD duration of 40.9 ± 26.3 months and 50.9 ± 41.5 months [16,17] respectively. This disparity between studies is related to the definition of PD technique failure adopted by each team. In some studies, technique failure was defined as a 30-day transfer to HD and others defined it as a transfer of 60 days or more. In the literature, the timing of transfer from PD to HD depends on the centers and definitions of the variables. The transfer at 6 months varied between 7% and 25%, while at 1 year it was between 21 and 44%. Eighty-eleven (91) patients developed infectious complications during their PD stay. The mean of infectious episodes was 3.36 episodes [1]. Eightynine (89) patients had peritoneal infections (97.80%). The mean time to onset of the first episode of peritoneal infection was 9.73 +/- 11.51 months [1]. In France in Le Maner’s series, 53.62% of patients transferred after 6 months of PD had presented one or more episodes of peritonitis [18]. While in the Béchade series, 2.60% of patients transferred early (during the first 6 months) had peritoneal infections [19]. In Australia, Lan et al. found that 50% of cases had peritoneal infections [4]. The occurrence of peritoneal infection within the first 6 months is considered a risk factor for transfer from PD to HD. This is explained by the structural modifications of the peritoneal membrane, which will result in the failure of the technique. The high rate of peritoneal infections in our study may be related to the tropical climate. The heat and humidity promote the loosening of the dressings and the proliferation of germs. Several teams, in Australia and Hong Kong, have shown that the rates of peritoneal infections vary with the seasons, and increase with temperature and humidity [20]. The main reason for transfer was infection, 76 (77.6%) patients were transferred due to peritoneal infection. In second place come the mechanical causes in 23.5% of the patients, and the social reasons come in third place in 12.2% of the cases then the inadequate dialysis in 6.1% of the cases. Severe undernutrition and sclerosis peritonitis accounted for only 1% each. Szeto et al. found that 71.1% of patients were transferred following peritoneal infection and catheter ablation while 28.9% of transfers were due to loss of UF and other medical causes [17]. In Panagoutsos’s serie , the causes of transfer were peritoneal infections (61%), loss of UF (27%), sclerosis peritonitis (9%) and social reasons (3%) [21]. The mean duration on haemodialysis in 53 patients was 43.29 ± 44.82 months. The majority of patients (42.8%) were still in HD, 34.6% of cases had died and one patient was transplanted (1%). According to Le Maner, 73 patients (62.4%) had died, 22 patients (18.8%) were transplanted, and 22 patients (18.8%) were still on hemodialysis [18]. In Szeto’s serie, 61.4% of patients had died, 18.3% were transplanted, 4.6% were transferred to another center and 15.7% were still in HD [17]. Thirty-four (34.6%) patients had died. Eight (61.5%) patients had died during the first 12 months of the transfer. Patient survival according to the Kaplan Meier method was on average 126.51 ± 11.66 months, and the median was 152 months. The 5-year survival was 77%. Szeto et al. found a 5-year survival of 39.9%. They also noted that mortality was high during the first 12 months. Analysis of survival in patients who remained alive after 12 first months showed a rate of 65.2% [17]. According to Habib et al. the mean survival was 79.2 months, and the median was 90 months [14]. While in Van Biesen’s serie, the median survival was 95.7 months [22].

Conclusion

The main reasons for transferring PD to haemodialysis identified in the literature are found in our context. This transfer must be anticipated to reduce morbidity and mortality.

For more Lupine Journals please click here: https://lupinepublishers.com/index.php

For more  Journal of Urology & Nephrology Studies  articles please click here: https://lupinepublishers.com/urology-nephrology-journal/index.php

[pratikkadbane]

Static Meters Market Research Report forecast year 2022 – 2027

The  “Static Meters ” Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Also Read : http://www.marketwatch.com/story/static-meters-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-07-05

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:

Maquet Cardiovascular

Perouse Medical

B. Braun

Terumo Group

LeMaitre Vascular

Gore

ShangHai CHEST

Jotec GmbH

Bard

Nicast

SuoKang

By Type

EPTFE

Polyethylene Terephthalate

Polyurethane

Others

By Application

Aortic Disease

Peripheral Artery Disease

Hemodialysis

By Regions/Countries:

North America

United States

Canada

Mexico

East Asia

China

Japan

South Korea

Europe

Germany

United Kingdom

France

Italy

Russia

Spain

Netherlands

Switzerland

Poland

South Asia

India

Pakistan

Bangladesh

Southeast Asia

Indonesia

Thailand

Singapore

Malaysia

Philippines

Vietnam

Myanmar

Middle East

Turkey

Saudi Arabia

Iran

United Arab Emirates

Israel

Iraq

Qatar

Kuwait

Oman

Africa

Nigeria

South Africa

Egypt

Algeria

Morocoo

Oceania

Australia

New Zealand

South America

Brazil

Argentina

Colombia

Chile

Venezuela

Peru

Puerto Rico

Ecuador

Rest of the World

Kazakhstan

Also Read : http://www.marketwatch.com/story/fighter-jet-aircraft-interface-device-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-atic-disk-brakes-data-and-news-2020-2025-2021-06-24

 Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Also Read : http://www.marketwatch.com/story/box-sealing-tapes-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2025-2021-06-23

 The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Static Meters  2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product Type: The report covers majority Product Types in the Static Meters  Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).

Markat Analysis by Application Type: Based on the Static Meters  Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Also Read : http://www.marketwatch.com/story/breakwater-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-forecast-year-2021-06-25

 Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact

Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Static Meters  market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Also Read : http://www.marketwatch.com/story/cable-blowing-machine-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-06-26

 Table of Content:

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Static Meters Revenue 1.4 Market Analysis by Type 1.4.1 Global Static Meters Market Size Growth Rate by Type: 2021 VS 2027 1.4.2 Minilaparotomy 1.4.3 Laparoscopy 1.4.4 Hysteroscopy 1.5 Market by Application 1.5.1 Global Static Meters Market Share by Application: 2022-2027 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Home 1.6 Study Objectives 1.7 Years Considered 1.8 Overview of Global Static Meters Market 1.8.1 Global Static Meters Market Status and Outlook (2016-2027) 1.8.2 North America 1.8.3 East Asia 1.8.4 Europe 1.8.5 South Asia 1.8.6 Southeast Asia 1.8.7 Middle East 1.8.8 Africa 1.8.9 Oceania 1.8.10 South America 1.8.11 Rest of the World 1.9 Global Market Growth Prospects 1.9.1 Global Static Meters Revenue Estimates and Forecasts (2016-2027) 1.9.2 Global Static Meters Production Capacity Estimates and Forecasts (2016-2027) 1.9.3 Global Static Meters Production Estimates and Forecasts (2016-2027) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material 2.2 Manufacturing Cost Structure Analysis of Static Meters 2.3 Manufacturing Process Analysis of Static Meters 2.4 Industry Chain Structure of Static Meters 3 Development and Manufacturing Plants Analysis of Static Meters 3.1 Top Manufacturers Headquarters, Rank by Static Meters Production 3.2 Global Static Meters Manufacturing Plants Distribution and Commercial Production Date 4 Market Competition by Manufacturers 4.1 Global Static Meters Production Capacity Market Share by Manufacturers (2016-2021) 4.2 Global Static Meters Revenue Market Share by Manufacturers (2016-2021) 4.3 Global Static Meters Average Price by Manufacturers (2016-2021) 4.4 Manufacturers Static Meters Production Sites, Area Served, Product Type 5 Static Meters Regional Market Analysis 5.1 Static Meters Production by Regions 5.1.1 Global Static Meters Production by Regions (2016-2021) 5.1.2 Global Static Meters Revenue by Regions 5.2 Static Meters Consumption by Regions 5.3 North America Static Meters Market Analysis 5.3.1 North America Static Meters Production 5.3.2 North America Static Meters Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Static Meters Import and Export 5.4 East Asia Static Meters Market Analysis 5.4.1 East Asia Static Meters Production 5.4.2 East Asia Static Meters Revenue 5.4.3 Key Manufacturers in East Asia 5.4.4 East Asia Static Meters Import & Export 5.5 Europe Static Meters Market Analysis

Continued…

 Contact Us:

Email: sales@hnyresearch.com  

Contact No:   US +1 213 262 0912

UK +44 20 8133 1382

[hrugved02]

Trypsin Market Research Report forecast year 2022 – 2027

The “Trypsin” Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Also Read: http://www.marketwatch.com/story/trypsin-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-forecast-to-2026-2021-07-05

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:

Maquet Cardiovascular

Perouse Medical

B. Braun

Terumo Group

LeMaitre Vascular

Gore

ShangHai CHEST

Jotec GmbH

Bard

Nicast

SuoKang

By Type

EPTFE

Polyethylene Terephthalate

Polyurethane

Others

By Application

Aortic Disease

Peripheral Artery Disease

Hemodialysis

By Regions/Countries:

North America

United States

Canada

Mexico

East Asia

China

Japan

South Korea

Europe

Germany

United Kingdom

France

Italy

Russia

Spain

Netherlands

Switzerland

Poland

South Asia

India

Pakistan

Bangladesh

Southeast Asia

Indonesia

Thailand

Singapore

Malaysia

Philippines

Vietnam

Myanmar

Middle East

Turkey

Saudi Arabia

Iran

United Arab Emirates

Israel

Iraq

Qatar

Kuwait

Oman

Africa

Nigeria

South Africa

Egypt

Algeria

Morocoo

Oceania

Australia

New Zealand

South America

Brazil

Argentina

Colombia

Chile

Venezuela

Peru

Puerto Rico

Ecuador

Rest of the World

Kazakhstan

Also Read : http://www.marketwatch.com/story/noodle-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2025-2021-06-24

Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Also Read : http://www.marketwatch.com/story/vibration-sieves-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2026-2021-06-23

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Trypsin  2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product Type: The report covers majority Product Types in the Trypsin  Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).

Markat Analysis by Application Type: Based on the Trypsin  Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Also Read : http://www.marketwatch.com/story/chromatography-reagents-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-atic-disk-brakes-data-and-news-2021-2027-2021-06-25

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact

Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Trypsin  market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Also Read : http://www.marketwatch.com/story/food-texture-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2027-2021-06-26

Table of Content:

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Trypsin Revenue 1.4 Market Analysis by Type 1.4.1 Global Trypsin Market Size Growth Rate by Type: 2021 VS 2027 1.4.2 Minilaparotomy 1.4.3 Laparoscopy 1.4.4 Hysteroscopy 1.5 Market by Application 1.5.1 Global Trypsin Market Share by Application: 2022-2027 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Home 1.6 Study Objectives 1.7 Years Considered 1.8 Overview of Global Trypsin Market 1.8.1 Global Trypsin Market Status and Outlook (2016-2027) 1.8.2 North America 1.8.3 East Asia 1.8.4 Europe 1.8.5 South Asia 1.8.6 Southeast Asia 1.8.7 Middle East 1.8.8 Africa 1.8.9 Oceania 1.8.10 South America 1.8.11 Rest of the World 1.9 Global Market Growth Prospects 1.9.1 Global Trypsin Revenue Estimates and Forecasts (2016-2027) 1.9.2 Global Trypsin Production Capacity Estimates and Forecasts (2016-2027) 1.9.3 Global Trypsin Production Estimates and Forecasts (2016-2027) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material 2.2 Manufacturing Cost Structure Analysis of Trypsin 2.3 Manufacturing Process Analysis of Trypsin 2.4 Industry Chain Structure of Trypsin 3 Development and Manufacturing Plants Analysis of Trypsin 3.1 Top Manufacturers Headquarters, Rank by Trypsin Production 3.2 Global Trypsin Manufacturing Plants Distribution and Commercial Production Date 4 Market Competition by Manufacturers 4.1 Global Trypsin Production Capacity Market Share by Manufacturers (2016-2021) 4.2 Global Trypsin Revenue Market Share by Manufacturers (2016-2021) 4.3 Global Trypsin Average Price by Manufacturers (2016-2021) 4.4 Manufacturers Trypsin Production Sites, Area Served, Product Type 5 Trypsin Regional Market Analysis 5.1 Trypsin Production by Regions 5.1.1 Global Trypsin Production by Regions (2016-2021) 5.1.2 Global Trypsin Revenue by Regions 5.2 Trypsin Consumption by Regions 5.3 North America Trypsin Market Analysis 5.3.1 North America Trypsin Production 5.3.2 North America Trypsin Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Trypsin Import and Export 5.4 East Asia Trypsin Market Analysis 5.4.1 East Asia Trypsin Production 5.4.2 East Asia Trypsin Revenue 5.4.3 Key Manufacturers in East Asia 5.4.4 East Asia Trypsin Import & Export 5.5 Europe Trypsin Market Analysis

Continued…

Contact Us:

Email: sales@hnyresearch.com  

Contact No:   US +1 213 262 0912

UK +44 20 8133 1382

[healthcare-domain]

Continuous Renal Replacement Therapy Market Analysis, Revenue Status, Sales and Segmentation Analysis 2026

The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about CRRT therapy along with the increase in the launch of advanced CRRT system area anticipated to fuel the Continuous Renal Replacement Therapy Market growth during the forecast period.

The CRRT market includes major Tier I and II suppliers of CRRT products are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. s.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China),

These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. The early initiation of continuous renal replacement therapy (CRRT) is an important step to curbing the rising incidence of AKI due to the COVID-19 infection. However, owing to the rapid rise in the demand by healthcare systems, HD and PD exist as an alternative dialysis treatment in ICUs, which can have a negative impact on the growth of the CRRT market during this period.

The growing demand for dialysate to support the market growth during the forecast period.

The significant rise in demand for CRRT in the treatment of hemodynamically unstable patients. Moreover, the development and commercialization of novel renal replacement solutions also support market growth. Furthermore, many companies are expanding their dialysate product portfolios. For instance, in August 2020, NIPRO CORPORATION acquired shares in dialysate MTN Neubrandenburg GmbH, involved in the manufacturing and sales of dialysates. Additionally, there has been an increase in the global incidence of acute kidney injury (AKI), which has driven the demand for dialysates and prompted manufacturers to ramp up dialysate production.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246917088

Asia Pacific likely to emerge as the fastest-growing Continuous Renal Replacement Therapy Market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.7% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with acute kidney disease, diabetes, hypertension are factors likely to support the growth of CRRT market in the region.

According to the new market research report "Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates) – Global Forecasts to 2026", published by MarketsandMarkets™, the global CRRT Market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period.

Browse in-depth TOC on "Continuous Renal Replacement Therapy (CRRT) Market"

126 – Tables 39 – Figures 181 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24691708

The growing worldwide incidence of AKI/AKF is, therefore, expected to increase the demand for CRRT. According to the International Society of Nephrology (INR), an estimated 13.3 million cases of AKI are registered annually worldwide. This is anticipated to boost the adoption of continuous renal replacement therapy at a rapid rate. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the CRRT market at a significant rate during the forecast period.